Scientists in Japan have found a way to create solar-powered tissues, which may lead to breakthroughs in growing organs and ...

so the CAR T-cell therapies eliminate some healthy cells. However, patients can survive without B cells. With solid tumors, ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's ...

The expression of MICA/B cell-surface proteins is induced by cellular stress or malignant transformation, and is detectable ...

The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...

In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...

By staying alert to skin symptoms and knowing what to look for you can take the first steps toward addressing a potential ...